Radiosynthesis and Preclinical Evaluation of Enantiopure (R)-[(18)F]Fluorolactate for PET Imaging of Metabolic Processes.

Zhuang X, Virta J, Samani NA, Airenne TT, Miner MWG, Liljenbäck H, Latva-Rasku A, Gerami M, Ponkamo J, Läpinen N, Dillemuth P, Rajander J, Salminen TA, Enerbäck S, Nuutila P, Li XG, Roivainen A

Open source

DOI
10.1021/acs.molpharmaceut.6c00236
Published
2026 Jul 26
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.6c00236,
  title = {Radiosynthesis and Preclinical Evaluation of Enantiopure (R)-[(18)F]Fluorolactate for PET Imaging of Metabolic Processes.},
  author = {Zhuang X and Virta J and Samani NA and Airenne TT and Miner MWG and Liljenbäck H and Latva-Rasku A and Gerami M and Ponkamo J and Läpinen N and Dillemuth P and Rajander J and Salminen TA and Enerbäck S and Nuutila P and Li XG and Roivainen A},
  year = {2026},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.6c00236},
  url = {https://doi.org/10.1021/acs.molpharmaceut.6c00236}
}

RIS

TY  - JOUR
TI  - Radiosynthesis and Preclinical Evaluation of Enantiopure (R)-[(18)F]Fluorolactate for PET Imaging of Metabolic Processes.
AU  - Zhuang X
AU  - Virta J
AU  - Samani NA
AU  - Airenne TT
AU  - Miner MWG
AU  - Liljenbäck H
AU  - Latva-Rasku A
AU  - Gerami M
AU  - Ponkamo J
AU  - Läpinen N
AU  - Dillemuth P
AU  - Rajander J
AU  - Salminen TA
AU  - Enerbäck S
AU  - Nuutila P
AU  - Li XG
AU  - Roivainen A
PY  - 2026
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.6c00236
UR  - https://doi.org/10.1021/acs.molpharmaceut.6c00236
ER  - 

APA

X, Z., J, V., NA, S., TT, A., MWG, M., H, L., A, L., M, G., J, P., N, L., P, D., J, R., TA, S., S, E., P, N., XG, L., & A, R. (2026). Radiosynthesis and Preclinical Evaluation of Enantiopure (R)-[(18)F]Fluorolactate for PET Imaging of Metabolic Processes.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00236

Source records